Rothschild & Co Asset Management US’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-8,735
Closed -$700K 607
2016
Q4
$700K Buy
8,735
+1,108
+15% +$87.9K 0.01% 435
2016
Q3
$608K Buy
7,627
+2,275
+43% +$184K 0.01% 399
2016
Q2
$417K Buy
+5,352
New +$382K 0.01% 468
2016
Q1
Sell
-12,872
Closed -$795K 572
2015
Q4
$795K Buy
12,872
+3,608
+39% +$228K 0.01% 330
2015
Q3
$584K Sell
9,264
-159
-2% -$11.3K 0.01% 329
2015
Q2
$689K Hold
9,423
0.01% 323
2015
Q1
$616K Hold
9,423
0.01% 326
2014
Q4
$613K Sell
9,423
-455
-5% -$29.3K 0.01% 341
2014
Q3
$595K Sell
9,878
-818
-8% -$53.4K 0.01% 339
2014
Q2
$741K Sell
10,696
-465,729
-98% -$30.2M 0.02% 343
2014
Q1
$31.2M Buy
476,425
+18,404
+4% +$1.2M 0.69% 22
2013
Q4
$28.2M Sell
458,021
-47,215
-9% -$2.73M 0.63% 30
2013
Q3
$27.1M Buy
+505,236
New +$26M 0.59% 40

Other funds holding STJ

Rothschild & Co Asset Management US's STJ Position: Q1 2017 in Review

Rothschild & Co Asset Management US sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,735 shares — an estimated $700K sold.

Rothschild & Co Asset Management US first reported a position in STJ in Q3 2013 and held it in 13 quarters. The position peaked at $31.2M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Rothschild & Co Asset Management US reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 8,735 St Jude Medical shares in Q1 2017, an estimated $700K.
  • Rothschild & Co Asset Management US first reported a position in St Jude Medical in Q3 2013 and held it in 13 quarters.
  • Rothschild & Co Asset Management US's St Jude Medical position peaked at $31.2M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2017, filed 12 May 2017.